reduc estim reflect us hospit
lockdown reduc target
reiter outperform
chang model made chang model reflect revis
analysi framework incorpor near-term pressur us elect surgeri
addit
mdt major
busi reduc ep estim
respect also reduc sale estim
bil bil respect reflect organ growth
respect previou estim despit
sharp drop elect surgeri back half march expect declin april
expect surgeri begin open back may eas
restrict june juli remain consider uncertainti rate
return surgeri potenti impact flu season
hospit protocol believ analysi framework captur much potenti
rang effect comfort point base case scenario
reflect new estim middl rang lower target price
reiter outperform rate
new estim reflect base case assumpt across rang risk
factor analysi contempl potenti impact defer procedur
procedur less deferr capit equip flu care diagnost
busi line also take account geograph exposur mdt major
busi china apac ex-china ou ex-apac us final consid
potenti rang durat may see pressur slowdown variou
busi degre hospit system may oper partial
capac differ time next month expect measur pace
surgeri begin certain center certain region mid-may
improv june juli also revis framework assum
greater portion base case lost defer procedur reschedul
ultim perform next sever quarter addit detail analysi
framework behind estim chang pleas see correspond sector
updat estim revis make reduct estim
valuat metric
number share
 close
legal entiti disclosur statu non-u analyst us disclosur credit suiss seek busi
compani cover research report result investor awar firm may conflict interest could
affect object report investor consid report singl factor make invest decis
mariu zoican univers toronto rotman school manag april
profit tax
chang work capit
flow oper
free cash-flow firm
flow invest
chang net cash/debt
total liabil equiti
share wtd average
price book
roe stated-return
price
medtron plc global manufactur provid medic devic
equip area cardiac rhythm manag vascular
intervent structur valvular diseas spinal disord
neuromodul surgic equip diabet
one-year valuat scenario base
ev/ebitda ebitda estim bil
one-year valuat grey scenario base
ev/ebitda grey ebitda estim bil
 close
mariu zoican univers toronto rotman school manag april
chang model
figur chang model
 peripher gastrointestin mariu zoican univers toronto rotman school manag april
valuat target price base ebitda multipl
ntm ebitda estim bil one year forward bil risk product
delay unexpect execut issu failur progress long-term goal growth
margin potenti new litig regulatori qualiti issu greater expect impact
mariu zoican univers toronto rotman school manag april
compani mention price
matt miksic certifi view express report accur reflect person view subject compani
secur part compens directli indirectli relat specif recommend view express
report
